A discovery about how mucus thickness is regulated could help to improve airway-clearing treatment options for people with chronic respiratory conditions such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD).
New insights into the molecular mechanisms driving mucus viscosity were discovered by a Melbourne research team led by Associate Professor Ethan Goddard-Borger from the Walter and Eliza Hall Institute. The study was published in the journal Nature Communications.